key: cord-0739872-8iaxbnxp
authors: Perfecto, Arkaitz; Villalabeitia, Ibabe; Sendino, Patricia; Sarriugarte, Aingeru
title: Spontaneous retroperitoneal hematoma in critical patients with bilateral SARS-CoV-2 pneumonia()
date: 2022-04-26
journal: Cir Esp (Engl Ed)
DOI: 10.1016/j.cireng.2022.04.010
sha: 5c2c7b52a8d2aab6ae9c23b7588048af700675a0
doc_id: 739872
cord_uid: 8iaxbnxp

nan

This is a PDF file of an article that has undergone enhancements after acceptance, such as the addition of a cover page and metadata, and formatting for readability, but it is not yet the definitive version of record. This version will undergo additional copyediting, typesetting and review before it is published in its final form, but we are providing this version to give early visibility of the article. Please note that, during the production process, errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain. 

SARS-CoV2, COVID, Hematoma Retroperitoneal, Angio-embolización.

Ninguno de los autores manifiesta conflictos de interés.

To the Editor:

The article recently published by Simón et al reports a case of bilateral psoas muscle hematoma due to SARS-CoV-2 infection in a critically ill patient. 1 We have recently identified 2 cases that share similar characteristics.

The patients are 2 men, aged 64 and 78 years, who required anticoagulation and postural changes to prone position in the context of ICU treatment for severe SARS-CoV-2 pneumonia. On days 30 and 37 after diagnosis, respectively, both patients presented sudden anemia with no apparent signs of external bleeding. CT angiographies were requested, which found right retroperitoneal hematomas measuring 7 × 14 × 22.5 cm and 15 × 13 × 17 cm ( Figure 1A and 2A) and signs of active bleeding from branches of the lumbar L1, iliolumbar and iliac circumflex arteries ( Figure 1B) , and lumbar L3-4 and iliolumbar arteries ( Figure 2B) , which were embolized. The subsequent evolution of both patients was satisfactory.

Other authors in our setting, such as Pardal-Fernández et al, have also reported several cases of retroperitoneal bleeding with involvement of the psoas in patients with severe SARS-CoV22 infection. Similarly, they have studied the pathogenesis of this infrequent condition, emphasizing that the most relevant circumstance in these patients could be the anticoagulation indicated in order to minimize the intense thrombotic effects of the virus, which are a consequence of the endotheliitis and proinflammatory state derived from their binding to angiotensin-converting enzyme receptors in the microvascular endothelium. In addition, they refer to prolonged prone positions and postural changes as favoring retroperitoneal bleeding.

The patient profile usually includes severe COVID infection, with the need for anticoagulation and prolonged ICU hospitalization. 3,4 Symptoms at presentation may include abdominal pain, anemia, lumbar polyneuropathy with motor deficits in the lower extremities, tachycardia, or hypotension, even in exceptional circumstances such as ECMO therapy. 5

Depending on the degree of hemodynamic impact, the initial treatment must include the withdrawal or a reduced dose of anticoagulants and fluid resuscitation. The need for vasoactive drugs and transfusion support should be assessed. Several experiences of definitive management based on angioembolization have been described with favorable results, which was also our experience with our patients. 4, 5 There is a well-known relationship between SARS-CoV-2 and thrombotic phenomena. However, we feel it is necessary to make this condition of spontaneous retroperitoneal hemorrhages known, as they are probably the result of anticoagulant use or consumptive coagulopathies. Publications about this rare complication are scarce and isolated in most cases. It would be interesting to plan a systematic review of the international literature to obtain greater levels of evidence. 

Catastrophic retroperitoneal hemorrhage in COVID-19 patients under anticoagulant prophylaxis

Life-Threatening Psoas Hematoma due to Retroperitoneal Hemorrhage in a COVID-19 Patient on Enoxaparin Treated With Arterial Embolization: A Case Report

None of the authors have conflicts of interests to declare.